Individual decision · SEC · 22 Jan 2007

SEC Division of Trading and Markets no-action letter: HealthShares Emerging Cancer Exchange-Traded Fund and HealthShares Cardio Devices Exchange-Traded Fund

The Commission grants exemptions from Rules 10a-1, 10b-17, and 14e-5 under the Exchange Act, and interpretations of Rules 101 and 102 of Regulation M, and a no-action position under Rule 200(g) of Regulation SHO, to HealthShares, Inc. and the HealthShares Emerging Cancer and Cardio Devices Exchange-Traded Funds. The exemption from Rule 10a-1 permits sales of the Funds without regard to tick requirements, contingent upon the Funds maintaining at least 20 component stocks. The Staff will not recommend enforcement action under Rule 200(g) if broker-dealers mark exempt short sales as "short" rather than "short exempt," provided market centers mask the short sale character and maintain audit trails. The Commission also confirms that the Funds are excepted from Regulation M restrictions, allowing persons participating in distributions to bid for or purchase the Funds and permitting the Funds to redeem Creation Units during continuous offerings.

US FederalSecurities and Exchange Commission

More like this from SEC

SEC published 7 documents in the last 30 days. We email you each new one the day it's published.

Source: Securities and Exchange Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

In RegAlert: added · updated